FDA Launches Drug Potency Testing as a $3,900 GLP-1 Program Draws Scrutiny
The Food and Drug Administration has launched a program to test drugs sold at pharmacies and wholesalers, confirming that products contain the listed active ingredient and meet standards for purity and potency. The agency also created an independent council to oversee the postmarketing safety of vaccines, gene therapies and other biologic products. Elsewhere in the week's health news, a woman described a $3,900 GLP-1 program at an island resort, a federal physician-appointee promoted unproven supplements online, and a cruise ship outbreak sickened more than 100 passengers and crew. The stories highlight ongoing questions about product quality, consumer claims and public health response.










